Replies to post #129320 on Cytodyn Inc (CYDY)

[misiu143]

LOL83001 , of course Bamlanivimab is approved only at the beginning of the infection , like REGN-cov2 it is an antibody/antibodies neutralizing this virus , and do nothing to immune problems ,

Actually , personally I don't know why NIH wasted taxpayers money , and more important the time , to do studies for severe patients with REG-cov2 ,

Instead they should spend this money for drugs having realistic chance to work for severe patients ..

NIH , FDA are expected to know what they are doing ,..

Those are antiviral antibodies , and starting about 8-10 days of this disease , as immunological problems increase , viral load is going down , and in some severe/critical patients , viral load is zero..
So how those neutralizing virus antibodies could work ??

What a waste of time and money is my opinion...

But just IMO..